China's AGI Pioneer and Leader Z.ai Listed on Hong Kong Stock Exchange - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # China's AGI Pioneer and Leader Z.ai Listed on Hong Kong Stock Exchange ##### Up next ![ATFX Officially Partners with Argentine Football Association as Regional Sponsor](https://i0.wp.com/mma.prnasia.com/media2/2857456/ATFX_Fifa_World_Cup_AFA_PR_2560x1440_EN.jpg?resize=200%2C110&ssl=1 "ATFX Officially Partners with Argentine Football Association as Regional Sponsor") [](https://thailandbusinessnews.net/press-release/atfx-officially-partners-with-argentine-football-association-as-regional-sponsor/) ###### [ATFX Officially Partners with Argentine Football Association as Regional Sponsor](https://thailandbusinessnews.net/press-release/atfx-officially-partners-with-argentine-football-association-as-regional-sponsor/) Published on 08 January 2026 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) SHANGHAI, Jan. 8, 2026 /PRNewswire/ — Qiming Venture Partners’ portfolio company Z.ai (formerly known as Zhipu AI), a pioneer and leader inartificial general intelligence (AGI) in China, successfully listed on the Hong Kong Stock Exchange on January 8th, 2026, Beijing time, becoming the world’s first listed large language model company. Z.ai (02513.HK) issued shares at a price of HK$116.20 per share and opened at HK$120.00 per share with a market capitalization of HK$52.83 billion. Qiming Venture Partners co-led Z.ai’s Series B1 financing round in early 2022, nearly a year before ChatGPT was released and sparked the global wave of large models. This funding was instrumental in supporting Z.ai to overcome R&D challenges and complete its first 100-billion-parameter large model, GLM. Qiming continued to support the company in its subsequent B2& B4funding round. Under Chapter 18C of the Hong Kong Stock Exchange, Qiming stands as Z.ai’s experienced independent investor Z.ai was founded in 2019 as a commercialization of technological achievements from Tsinghua University. With the mission "to make machines think like humans", the company has remained dedicated to AGI research and development. Since its inception, Z.ai has launched China’s first 10-billion-parameter model, its first open-source 100-billion-parameter model, its first conversational model, its first multimodal model, and the world’s first device-control AI agent. It has built one of the world’s most advanced and comprehensive model portfolios and AI agent products. GLM achieves breakthrough in full domesticization, supports over 40 domestic chips, becoming one of the most versatile model architectures in the industry. Its latest flagship model,GLM-4.7, has delivered top-tier performance among open-source models across multiple mainstream public benchmarks. In CodeArena, an authoritative coding evaluation system with global participation from a million users in blind testing, GLM-4.7 ranks first among open-source models and first among domestic models, surpassing GPT-4. Additionally, on the highly authoritative AA AI Index, the model also secured first place among open-source models and first among domestic models. The released GLM Coding Plan has already gained 150,000 users globally, establishing itself as a primary programming model solution for Chinese developers. Today, Z.ai has grown into China’s largest independent large language model developer. Its GLM series of models are applied across various sectors including public governance, industrial manufacturing, energy and power, finance, internet, communications, consumer electronics, and education. As of September 30, 2025, Z.ai’s models had empowered over 12,000 enterprise customers, more than 80 million end-user devices, and over 45 million developers worldwide, making it the independent general-purpose large-model vendor in China with the highest number of enabled end-user devices. Zhang Peng, CEO of Z.ai, stated: "Listing in Hong Kong represents a landmark milestone for Z.ai. Our journey—from commercializing research outcomes at Tsinghua’s labs to becoming a publicly listed company—has never strayed from our original vision: ‘to make machines think like humans’. Going public means we must shoulder even greater social responsibility and industry mission. Moving forward, Z.ai will continue to deepen our commitment to fully independent, controllable full-stack large model technology, relentlessly push the boundaries of AGI capabilities, and consistently enhance the reasoning, coding, and multimodal performance of the GLM model series. We are dedicated to building a more open and thriving AI ecosystem, empowering thousands of industries through accessible and inclusive technology, and making General Artificial Intelligence a genuine productive force for the advancement of human civilization." Alex Zhou, Managing Partner of Qiming Venture Partners, said, "The Z.ai team combines deep conviction in its technical roadmap with a rare ability to consistently translate frontier research into real commercial value. This dual strength—a strong belief in technology coupled with disciplined industrial execution—gives us confidence that the company will navigate the AI wave with resilience and emerge as a category leader. Z.ai’s successful IPO is not only a critical validation of China’s path in foundational AI innovation, but also sends a clear signal to the broader technology investment community: in the long run, the market recognizes and rewards teams that stay committed to frontier exploration and deep, foundational technological breakthroughs. We look forward to Z.ai building on this milestone and continuing to drive innovation in large language model technology and real-world applications, creating even greater value for the AI ecosystem." About Qiming Venture Partners Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages. Since our debut, we have backed over 580 fast-growing and innovative companies. Over 210 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 80 portfolio companies that have achieved unicorn or super unicorn status. Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, HyperStrong, Insta360, Unisound, Biren Technology, Z.ai (02513.HK), Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, Insilico Medicine, AusperBio, Yuanxin Technology, Medilink Therapeutics, LaNova Medicines, StepFun, among many others. [Source link ](http://www.prnasia.com/story/archive/4859068_AE59068_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/biodlinks-bevacizumab-approved-for-market-launch-in-nigeria-accelerating-global-expansion/) ## BioDlink's Bevacizumab Approved for Market Launch in Nigeria, Accelerating Global Expansion BioDlink’s Bevacizumab Injection has been granted marketing authorization by Nigeria’s National Agency… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - June 16, 2025 [](https://thailandbusinessnews.net/press-release/aimx-singapore-2026-anchors-strategic-relationship-with-techinnovation-and-ai-gravity/) ![AIMX Singapore 2026 Anchors Strategic Relationship with TechInnovation and AI Gravity](https://i0.wp.com/mma.prnasia.com/media2/2982797/AIMX_2026___TI_2026_KV__1.jpg?resize=260%2C140&ssl=1 "AIMX Singapore 2026 Anchors Strategic Relationship with TechInnovation and AI Gravity") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## AIMX Singapore 2026 Anchors Strategic Relationship with TechInnovation and AI Gravity AIMX Singapore 2026 Unites Three Flagship Platforms in a Landmark Convergence of… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - May 19, 2026 [](https://thailandbusinessnews.net/press-release/auto-shanghai-2025-nullmax-showcases-full-stack-automated-driving-solutions/) ![Auto Shanghai 2025 – Nullmax Showcases Full-Stack Automated Driving Solutions](https://i0.wp.com/r2.thailandbusinessnews.net/2025/04/Auto_Shanghai_2025.jpg?resize=260%2C140&ssl=1 "Auto Shanghai 2025 – Nullmax Showcases Full-Stack Automated Driving Solutions") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Auto Shanghai 2025 – Nullmax Showcases Full-Stack Automated Driving Solutions SHANGHAI, April 24, 2025 /PRNewswire/ — On April 23rd, the biennial Shanghai International… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - April 24, 2025 ##### Most Read - [![BitRaser Receives Frost & Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/bitraser-receives-frost-sullivans-2026-global-customer-value-leadership-recognition-for-data-erasure-for-used-electronics/ "BitRaser Receives Frost & Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics") [BitRaser Receives Frost & Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics](https://thailandbusinessnews.net/press-release/bitraser-receives-frost-sullivans-2026-global-customer-value-leadership-recognition-for-data-erasure-for-used-electronics/ "BitRaser Receives Frost & Sullivan's 2026 Global Customer Value Leadership Recognition for Data Erasure for Used Electronics") - [![FGR advances carbon fibre commercialisation with Aeropreg agreement](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/fgr-advances-carbon-fibre-commercialisation-with-aeropreg-agreement/ "FGR advances carbon fibre commercialisation with Aeropreg agreement") [FGR advances carbon fibre commercialisation with Aeropreg agreement](https://thailandbusinessnews.net/press-release/fgr-advances-carbon-fibre-commercialisation-with-aeropreg-agreement/ "FGR advances carbon fibre commercialisation with Aeropreg agreement") - [![Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/celltrion-to-present-six-abstracts-in-inflammatory-bowel-disease-ibd-at-2025-digestive-disease-week-ddw/ "Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)") [Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)](https://thailandbusinessnews.net/press-release/celltrion-to-present-six-abstracts-in-inflammatory-bowel-disease-ibd-at-2025-digestive-disease-week-ddw/ "Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)") - [![Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection](https://i0.wp.com/r2.thailandbusinessnews.net/2025/03/1742866040_Power_Up_Teyvat_Journey_UGREEN_Launches_Genshin_Impact_Co_Branded_Charging.jpg?fit=600%2C324&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/power-up-the-teyvat-journey-ugreen-launches-genshin-impact-co-branded-charging-collection-4/ "Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection") [Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection](https://thailandbusinessnews.net/press-release/power-up-the-teyvat-journey-ugreen-launches-genshin-impact-co-branded-charging-collection-4/ "Power Up the Teyvat Journey: UGREEN Launches Genshin Impact Co-Branded Charging Collection") - [![Tuya Reports Second Quarter 2025 Unaudited Financial Results and Declaration of Cash Dividend](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/tuya-reports-second-quarter-2025-unaudited-financial-results-and-declaration-of-cash-dividend/ "Tuya Reports Second Quarter 2025 Unaudited Financial Results and Declaration of Cash Dividend") [Tuya Reports Second Quarter 2025 Unaudited Financial Results and Declaration of Cash Dividend](https://thailandbusinessnews.net/press-release/tuya-reports-second-quarter-2025-unaudited-financial-results-and-declaration-of-cash-dividend/ "Tuya Reports Second Quarter 2025 Unaudited Financial Results and Declaration of Cash Dividend") - [![CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/csl-and-alentis-announce-global-partnership-to-develop-and-commercialise-lixudebart-for-rare-kidney-and-liver-diseases/ "CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases") [CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases](https://thailandbusinessnews.net/press-release/csl-and-alentis-announce-global-partnership-to-develop-and-commercialise-lixudebart-for-rare-kidney-and-liver-diseases/ "CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/the-coffee-bean-tea-leaf-turns-63-and-sets-a-new-direction-for-its-next-chapter-of-growth/) ![The Coffee Bean & Tea Leaf® Turns 63 and Sets a New Direction for Its Next Chapter of Growth](https://i0.wp.com/mmx.prnasia.com/media/MS2001377/20261002012425EDT_image_1.jpg?resize=260%2C140&ssl=1 "The Coffee Bean & Tea Leaf® Turns 63 and Sets a New Direction for Its Next Chapter of Growth") ## The Coffee Bean & Tea Leaf® Turns 63 and Sets a New Direction for Its Next Chapter of Growth Global anniversary campaign marks the first step of the brand’s transformation… [](https://thailandbusinessnews.net/press-release/symphony-randomized-controlled-trial-demonstrates-significantly-improved-healing-of-diabetic-foot-ulcers/) ## Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers Published multicenter study found higher complete wound closure rates and faster… [](https://thailandbusinessnews.net/press-release/icac-and-unodc-jointly-debut-the-pioneering-prison-guide-icac-commissioner-charting-the-way-for-enhancing-global-prison-integrity/) ## ICAC and UNODC jointly debut the pioneering Prison Guide, ICAC Commissioner: charting the way for enhancing global prison integrity ABU DHABI, UAE and HONG KONG, Oct. 5, 2026 /PRNewswire/ — ICAC Commissioner… [](https://thailandbusinessnews.net/press-release/annji-pharmaceutical-advances-aj201-into-pivotal-phase-3-roma-kd-trial-for-spinal-and-bulbar-muscular-atrophy-sbma/) ## AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA) The only known investigational therapy for SBMA in Phase 3 development worldwide…